AGP Executive Report
Last update: 10 hours agoHealth Equity & Inequality: A UK op-ed argues that real health gains require action on social and economic conditions, warning that life expectancy improvements have stalled for years. Youth Sexual & Reproductive Health: The Netherlands pledges $16m to Uganda’s SAY Plus+ programme, aiming to expand youth-friendly SRHR services, prevent gender-based violence, and support young people’s wellbeing. Long-Term Care Staffing: Iceland’s Directorate of Health reports Hraunbúðir nursing home in Selfoss is far below staffing benchmarks, with only 27% professionally qualified staff and safety/communication issues flagged. Neuropsychiatric Drug Development: Iceland-headquartered Synaptiq launches with Nobias’ rare-disease drug programme, planning a Phase 2b trial of fasoracetam for 22q11.2 deletion syndrome symptoms. Cardiovascular Medicines: NewAmsterdam Pharma gets a positive CHMP opinion in Europe for obicetrapib (Ubeslo) and obicetrapib/ezetimibe (Evlarco) for primary hypercholesterolemia. Public Health & Prevention: Dietitians highlight high-protein breakfasts as a way to improve fullness and steady energy through the morning. Whaling Debate: Iceland’s whaling season resumes despite IUCN-linked concerns, with protests and quota-reduction calls in the spotlight.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
Pseudo-journalism: Pink-slime
